Sander Ruitenberg

Berufserfahrung von Sander Ruitenberg

• Bis heute 3 Monate, seit Feb. 2024

  Global Head of Omnichannel & Digital Operations

  CSL Vifor

• 7 Jahre und 3 Monate, Nov. 2016 - Jan. 2024

  Digital Health Solutions Head, Immunology

  Novartis

  Responsible for developing digital programs for the immunology portfolio, innovating customer engagement and service delivery models with an omnichannel focus. Created omnichannel customer engagement strategies and implementation models, and developed connected care programs with new ways to access product websites and connected solutions.

• 11 Monate, Mai 2022 - März 2023

  Digital Program Head, Connected Health (assignment

  Novartis

  Focus on building transformative governance frameworks and excellence models that will enable us to excel in Connected Health product design and development, as part of our Data & Digital efforts within Global Drug Development. In particular, these efforts will drive the activation of customer value via well designed and configured Connected Health product systems that are highly amenable to market adoption.

• 11 Monate, Mai 2020 - März 2021

  Global Business Owner, Novartis Chatbot Platform (assignment)

  Novartis

  Focused on building a chatbot platform in support of the Novartis chatbot portfolio, established a governance framework and development model, with an industry-leading platform approach.

• 1 Jahr und 5 Monate, Jan. 2019 - Mai 2020

  Global Business Owner, Dolphin Web Product (assignment)

  Novartis

  Led the development, launch and roll-out of a website product based on the Drupal content management framework.

• 3 Jahre und 9 Monate, Feb. 2013 - Okt. 2016

  Global Brand Director

  Novartis

  Launched Xolair® in dermatology for the chronic spontaneous urticaria indication and created the digital Novartis in dermatology presence with the “Skin to Live in” social media program.

• 6 Monate, Aug. 2012 - Jan. 2013

  Marketing consultant

  Glaxo Smith Kline

  Temporary transition support following the sale of Toctino® to GSK.

• 2 Jahre und 7 Monate, Jan. 2010 - Juli 2012

  Global Brand Director

  Basilea Pharmaceutica

  Lead the launch for Toctino® for chronic hand eczema and built a global multi-channel promotional platform.